197 related articles for article (PubMed ID: 25923322)
1. Tripeptide SQL Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling.
Su XL; Su W; He ZL; Ming X; Kong Y
J Cardiovasc Pharmacol; 2015 Sep; 66(3):254-60. PubMed ID: 25923322
[TBL] [Abstract][Full Text] [Related]
2. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
[TBL] [Abstract][Full Text] [Related]
3. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
[TBL] [Abstract][Full Text] [Related]
4. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
5. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
6. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
[TBL] [Abstract][Full Text] [Related]
7. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
8. Eisenia bicyclis (brown alga) modulates platelet function and inhibits thrombus formation via impaired P
Irfan M; Kwon TH; Yun BS; Park NH; Rhee MH
Phytomedicine; 2018 Feb; 40():79-87. PubMed ID: 29496178
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
10. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation.
Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH
J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226
[TBL] [Abstract][Full Text] [Related]
11. Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.
Su W; Chen Y; Wang C; Ding X; Rwibasira G; Kong Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):283-289. PubMed ID: 27012197
[TBL] [Abstract][Full Text] [Related]
12. Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor.
Nylander S; Kull B; Björkman JA; Ulvinge JC; Oakes N; Emanuelsson BM; Andersson M; Skärby T; Inghardt T; Fjellström O; Gustafsson D
J Thromb Haemost; 2012 Oct; 10(10):2127-36. PubMed ID: 22906130
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
[TBL] [Abstract][Full Text] [Related]
14. A novel di-peptide Met-Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq-mediated signaling.
Yang Y; Song H; Wang B; Tian Q; Li B
J Food Biochem; 2020 Sep; 44(9):e13352. PubMed ID: 32662128
[TBL] [Abstract][Full Text] [Related]
15. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis inhibited by Corydalis decumbens through regulating PI3K-Akt pathway.
Chen S; Tian CB; Bai LY; He XC; Lu QY; Zhao YL; Luo XD
J Ethnopharmacol; 2024 Jul; 329():118177. PubMed ID: 38604510
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
18. A tryptophan derivative TD-26 attenuates thrombus formation by inhibiting both PI3K/Akt signaling and binding of fibrinogen to integrin αIIbβ3.
Chen Y; Wang Y; Xie Z; Ming X; Li Z; Kong Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):516-22. PubMed ID: 26278818
[TBL] [Abstract][Full Text] [Related]
19. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
Xu HL; Feng YP
Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
[TBL] [Abstract][Full Text] [Related]
20. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
